Physician profile
Eva Rubin
NPI 1952437162
$14,914.91
in general payments reported to CMS, 2019-2025
34 companies · $7,042 in 2025
The $7,042 reported for 2025 was more than what 91% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,417 · 2020: $698 · 2021: $1,011 · 2022: $1,159 · 2023: $1,447 · 2024: $1,141 · 2025: $7,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,100 · Food and Beverage: $3,462 · Travel and Lodging: $756 · Education: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,100.00 |
| Food and Beverage | $3,462.29 |
| Travel and Lodging | $756.17 |
| Education | $310.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $6,441.07 | 2021-2025 | Tyvaso, Tyvaso |
| Astrazeneca Pharmaceuticals LP | $1,337.52 | 2020-2025 | Airsupra, Breztri, Symbicort |
| Bayer Healthcare Pharmaceuticals INC. | $1,092.27 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $958.60 | 2019-2024 | Jardiance, Ofev |
| Glaxosmithkline, LLC. | $932.65 | 2019-2024 | Trelegy Ellipta, Nucala, Arexvy |
| Amgen INC. | $485.32 | 2019-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $472.93 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $449.32 | 2022-2025 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $420.37 | 2021-2025 | Verquvo, Steglatro |
| Genzyme Corporation | $345.39 | 2022-2025 | |
| Olympus America INC. | $269.45 | 2022-2024 | Spin Vision Video Processor |
| Daiichi Sankyo INC. | $201.92 | 2022-2025 | Injectafer |
| Abbott Laboratories | $192.14 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $182.02 | 2020-2023 | Xarelto |
| Sanofi-Aventis U.S. LLC | $149.17 | 2020-2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $125.00 | 2022 | |
| Alexion Pharmaceuticals, INC. | $125.00 | 2021 | |
| Pulmonx Corporation | $125.00 | 2019 | |
| Ethicon INC. | $124.99 | 2021 | |
| Boston Scientific Corporation | $71.48 | 2024-2025 | Watchman Flx |
| Insmed, INC. | $65.69 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $53.03 | 2023-2024 | Inpefa |
| Baxter Healthcare | $53.01 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Amarin Pharma, INC. | $41.22 | 2020 | |
| Mallinckrodt Hospital Products INC. | $32.61 | 2020 | |
| Lilly USA, LLC | $26.67 | 2023 | Jardiance, Zepbound |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.68 | 2024 | Lifevest |
| Exact Sciences Corporation | $23.16 | 2023 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $17.49 | 2025 | Glassia |
| Inspire Medical Systems, INC. | $16.79 | 2023 | Inspire |
| Electromed, INC. | $16.06 | 2023 | Smartvest |
| Bardy Diagnostics, INC. | $16.00 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $15.35 | 2019 | |
| Philips North America LLC | $11.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Rubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.